• How PetaGene 'Nailed It' With Their PetaSuite Protect

    Bio-IT World | With the rapid growth of genomic data and the need for access by cross-functional teams, it is vital to ensure that this sensitive data is adequately protected and monitored. PetaGene's PetaSuite Protect ensures that protection.

    Jul 29, 2019

  • Novo Nordisk: Natural Language Processing On A Steady Diet Of Real-World Data

    Bio-IT World | Natural language processing is finding novel applications at Novo Nordisk, turning a trio of real-world data sources into a goldmine of knowledge about the medicines it makes, the healthcare providers who prescribe them, and patients who usually pay for a portion of the cost.

    Jul 29, 2019

  • First CRISPR Study Inside The Body To Start In US

    STAT | Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the body to try to cure an inherited form of blindness.

    Jul 25, 2019

  • Machine Reasoning Extends AI's Scope In Clinical Data Quality And Research

    Bio-IT World Contributed Commentary | Clinicians are faced with tedious data entry that can benefit by unobtrusive input verification and auto-completion. Coupling traditional data quality methods with AI makes it possible to efficiently solve issues like ensuring correct data, reporting to related systems, identifying medicine interactions, improving care processes—without changing clinical workflows.

    Jul 24, 2019

  • Genedata's 'No BS AI'

    Bio-IT World | Genedata recently won Bio-IT World's "No BS AI" Best of Show Award during the Bio-IT World Conference & Expo for its deep learning-based solution for phenotypic imaging and corresponding workflows, Imagence.

    Jul 22, 2019

  • 5 Ways To Keep Your Life Sciences Startup From Becoming Theranos

    Bio-IT World Contributed Commentary | Transparency is critical for all industries these days, but especially for the life sciences sector. When it comes to innovative services and products from emerging life sciences companies, transparency can be pivotal to preventing fraud and wasted investments.

    Jul 18, 2019

  • How The Parker Institute Addresses Tumor-Specific T Cells

    Bio-IT World | As a Senior Data Scientist at the Parker Institute for Cancer Immunotherapy, Daniel Wells sees how discoveries in immunotherapy are rapidly changing how researchers develop treatment strategies for patients by integrating multiple molecular and clinical data types.

    Jul 17, 2019

  • Building A Marriage Between Medicine And Tech

    Bio-IT World | John-William Sidhom says the ideal scenario would be to have a system where scientific research asks the relevant questions, tech provides answers to those questions, and the physician implements those solutions for the most clinical impact.

    Jul 12, 2019

  • St. Jude Announces Availability Of Clinical Genome Sequencing Data In Real Time Via Cloud

    Bio-IT World | St. Jude Children's Research Hospital has announced the real-time availability of clinical genome sequencing data on the St. Jude Cloud.

    Jul 11, 2019

  • Genomenon Provides Quick Answers On Fusion Genes

    Bio-IT World | For decades, clinicians and researchers have been fascinated by fusion genes—genomic abnormalities that form when part of the DNA from one chromosome moves to another chromosome. This helps explain the growing popularity of the Genomenon's Mastermind suite of software tools, which is more inclusive of all documented fusions.

    Jul 10, 2019

  • How Paratope Refinement Can Mitigate Antibody Polyspecificity

    Bio-IT World | There is often a lack of understanding in drug discovery about how polyspecificity drives antibody toxicity. This shows polyspecificity is an underappreciated phenomenon in therapeutic antibody development, but that these unwanted properties can be fully improved by paratope refinement.

    Jul 3, 2019

  • MELLODDY Using Federated Learning To Improve Drug Development

    Bio-IT World | A 17-partner consortium in Europe is seeking to confirm the utility of a machine learning platform for better predicting promising compounds for drug development. The three-year initiative, which launched in June, represents the first large-scale deployment of blockchain technology to extract insights from multiple preclinical datasets without having to first pool the data.

    Jul 2, 2019

  • LabTwin, AbCellera, X4, And More: News From June 2019

    Bio-IT World | June featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including LabTwin, AbCellera, X4, and more.

    Jul 1, 2019

  • The RGC UK Biobank Consortium Data Delivery And Cohort Browser

    Bio-IT World | The Regeneron Genetics Center has undertaken the exome sequencing and analysis of 500,000 samples from the UK Biobank, using the DNAnexus Platform to host the dataset and run Regeneron’s software pipeline. To increase the value to the RGC UKB consortium, Regeneron and DNAnexus partnered to construct a combined database of the UKB genomic and phenotypic data to explore through an innovative user interface.

    Jun 28, 2019

  • AbbVie, Discngine Collaborate On Structure-Based Drug Discovery Explorer

    Bio-IT World | Although wildly used, rational structure-based drug design techniques are far from being applied to their fullest potential. AbbVie and Discngine addressed the pitfalls by co-developing a web-based structural knowledge management solution called 3decision.

    Jun 26, 2019

  • Sentieon's 'Faster/Cheaper' Genomics Tools

    Bio-IT World | Sentieon's DNAseq and TNseq software, are making waves in the life sciences, creating a "drop in replacement" that is a faster and cheaper alternative to the industry standard for secondary analysis in next-generation sequencing (NGS) data processing while producing the industry standard results.

    Jun 25, 2019

  • Tracking The Clinical And Preclinical Progress In Targeting Membrane Proteins

    Bio-IT World | G protein-coupled receptors (GPCRs), ion channels, and transporters represent some of the most important drug target classes across a wide range of diseases. According to Catherine Hutchings, progress in targeting these membrane proteins requires a recognition of not only what works, but also what doesn't.

    Jun 24, 2019

  • Officials Say They Lack Authority To Halt CRISPR Babies Plan In Russia

    STAT | Two influential leaders in science for the first time publicly condemned a Russian biologist who said he plans to produce gene-edited babies but conceded that it was beyond their organizations’ authority to halt him from doing so.

    Jun 24, 2019

  • High-Confidence Characterization Of Small Molecule 'Unknowns': How Software Is Enabling Intelligent, High-Resolution Accurate Mass LC-MS/MS Data Acquisition

    Bio-IT World Contributed Commentary | Liquid chromatography-tandem mass spectrometry has proven to be a powerful tool for small molecule analysis. However, the identification of so-called "unknown-unknowns" is extremely challenging.

    Jun 17, 2019

  • Deep Genomics Identifies Rare Disease Targets Using AI System

    Bio-IT World News Brief | Deep Genomics' AI system has identified 1,600 rare disease targets that can be drugged using its splice-switching oligonucleotide technology.

    Jun 14, 2019